Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis.


Journal

Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 02 10 2018
accepted: 15 05 2019
pubmed: 28 5 2019
medline: 25 2 2020
entrez: 26 5 2019
Statut: ppublish

Résumé

For Japanese patients with non-valvular atrial fibrillation (NVAF), the risk of stroke and major bleeding events was assessed by using the CHADS

Identifiants

pubmed: 31127325
doi: 10.1007/s00380-019-01425-x
pii: 10.1007/s00380-019-01425-x
pmc: PMC6794239
doi:

Substances chimiques

Factor Xa Inhibitors 0
Rivaroxaban 9NDF7JZ4M3

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1839-1851

Commentaires et corrections

Type : ErratumIn

Références

Circ J. 2015;79(8):1719-26
pubmed: 25971525
Circ J. 2014;78(7):1593-9
pubmed: 24759791
Int J Cardiol. 2015 Feb 15;181:247-54
pubmed: 25528530
Nihon Rinsho. 2013 Jan;71(1):15-20
pubmed: 23631166
Chest. 2010 Nov;138(5):1093-100
pubmed: 20299623
Eur Heart J. 2016 Oct 7;37(38):2893-2962
pubmed: 27567408
Am J Med. 2018 May;131(5):574.e13-574.e27
pubmed: 29274754
Circ J. 2015;79(2):432-8
pubmed: 25501800
Circulation. 2012 Apr 3;125(13):1605-16
pubmed: 22374183
Lancet. 2016 Jun 4;387(10035):2302-2311
pubmed: 27056738
Int J Cardiol. 2018 May 1;258:126-132
pubmed: 29429636
Circ J. 2006 Jun;70(6):651-6
pubmed: 16723782
Circ J. 2018 Apr 25;82(5):1327-1335
pubmed: 29526914
Thromb Haemost. 2017 Oct 5;117(10):1848-1858
pubmed: 28799620
J Am Coll Cardiol. 2018 Jan 16;71(2):122-132
pubmed: 29325634
Circ J. 2013;77(9):2226-31
pubmed: 23902998
Eur Heart J. 2016 May 21;37(20):1582-90
pubmed: 26920728
Eur Heart J Qual Care Clin Outcomes. 2018 Jan 1;4(1):59-68
pubmed: 28950373
Eur Heart J. 2010 Oct;31(19):2369-429
pubmed: 20802247
Intern Med. 2017 Nov 1;56(21):2827-2836
pubmed: 28943575
J Am Heart Assoc. 2016 Sep 12;5(9):
pubmed: 27620886
Int J Cardiol. 2009 Oct 2;137(2):102-7
pubmed: 18691774
Circ J. 2014;78(8):1997-2021
pubmed: 24965079
JAMA. 2001 Jun 13;285(22):2864-70
pubmed: 11401607
Tohoku J Exp Med. 2016;240(4):259-268
pubmed: 27904005

Auteurs

Ichiro Sakuma (I)

Cardiovascular Medicine, Hokko Memorial Clinic, Sapporo, Hokkaido, Japan.

Shinichiro Uchiyama (S)

Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, International University of Health and Welfare, 8-5-35 Akasaka, Minato-ku, Tokyo, Japan.

Hirotsugu Atarashi (H)

Minamihachioji Hospital, 3-18-12, Koyasu-cho, Hachioji, Tokyo, Japan.

Hiroshi Inoue (H)

Saiseikai Toyama Hospital, 33-1, Kusunoki, Toyama, Toyama, Japan.

Takanari Kitazono (T)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, Fukuoka, Japan.

Takeshi Yamashita (T)

Cardiovascular Institute Hospital, 3-2-19 Nishiazabu, Minato-Ku, Tokyo, Japan.

Wataru Shimizu (W)

Department of Cardiovascular Medicine, Graduate School of Medicine, Nippon Medical School, 1-1-5, Bunkyo-ku, Sendagi, Tokyo, Japan.

Takanori Ikeda (T)

Department of Cardiovascular Medicine, Faculty of Medicine, Toho University, 5-21-16, Omorinishi, Ota-ku, Tokyo, Japan.

Masahiro Kamouchi (M)

Department of Health Care Administration and Management, Center for Cohort Study, Kyushu University Graduate School of Medical Sciences, 3-1-1, Maidashi, Higashi-ku, Fukuoka, Fukuoka, Japan.

Koichi Kaikita (K)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 2-39-1, Kurokami Chuo-ku, Kumamoto, Kumamoto, Japan.

Koji Fukuda (K)

Division of Heart Rhythm, International University of Health and Welfare Hospital, International University of Health and Welfare, 537-3, Iguchi, Nasushiobara, Tochigi, Japan.

Hideki Origasa (H)

Division of Biostatistics and Clinical Epidemiology, University of Toyama Graduate School of Medicine, 2630 Sugitani, Toyama, Toyama, Japan.

Hiroaki Shimokawa (H)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1, Seiryomachi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan. shimo@cardio.med.tohoku.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH